Related Experiment Videos
[Tactics in using antibiotics in diffuse forms of chronic nonspecific pneumonia in children]
Insights
This study evaluated antibacterial treatments for purulent endobronchitis in children with chronic pneumonia. A comprehensive treatment program achieved significant positive outcomes in most patients.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- Purulent endobronchitis is a common complication in children with chronic pneumonia.
- Effective antibacterial treatment strategies are crucial for managing this condition.
Purpose of the Study:
- To evaluate a comprehensive antibacterial treatment program for purulent endobronchitis in children with chronic pneumonia.
- To assess the efficacy of etiotropic antibiotic therapy, tailored to the infectious inflammatory process, and immunomodulating therapy.
Main Methods:
- Long-term clinical study involving children with chronic pneumonia and purulent endobronchitis.
- Implementation of a complex treatment program including etiotropic antibiotics and immunomodulating therapy.
- Monitoring of treatment outcomes and patient stabilization over 1.5 to 3 years.
Main Results:
- The integrated treatment program resulted in good direct outcomes in 87.6% of pediatric patients.
- Stabilization of endobronchitis was achieved in 47% of patients within 1.5 to 3 years.
- The study highlights the effectiveness of a tailored, multi-faceted approach to treating this condition.
Conclusions:
- A complex program of antibacterial and immunomodulating therapy is effective for treating purulent endobronchitis in children with chronic pneumonia.
- Tailoring antibiotic administration to the specific infectious inflammatory process is key to successful treatment.
- The findings support the integration of this comprehensive approach into clinical practice for improved patient outcomes.
Abstract:
The authors provide the results obtained during many years of studying different aspects of antibacterial treatment of purulent endobronchitis in children with prevalent forms of chronic pneumonia. The study was attempted at the clinic for disease of childhood, I.M. Sechenov Moscow Medical Academy. Base the complex program of such treatment, which rests on etiotropic , correspondence of the antibiotic administration to the activity of the infectious inflammatory process in the bronchi, and immunomodulating therapy carried out according to indications if any. Introduction of the antibiotic therapy program into clinical practice allowed the attainment of good direct results in 87.6% of patients and of stabilization of endobronchitis in 47% of patients within 1.5 to 3 years.